Analytical Data
-
基因名
DLST
- Application
-
别名
(2-oxoglutarate dehydrogenase complex component E2)(OGDC-E2)(Dihydrolipoamide succinyltransferase component of 2-oxoglutarate dehydrogenase complex)(E2K)
-
种属
Rat
-
表达系统
E. coli
-
标签
N- His & C- Myc
-
纯度
Greater than 90% as determined by SDS-PAGE.
-
蛋白编号
Q01205
-
表达区间
69-454aa
-
分子量
48.9 kDa
-
内毒素
< 1.0 EU per μg protein as determined by the LAL method.
-
性状
Freeze-dried powder
-
缓冲液
PBS, pH7.4, containing 0.01% SKL, 1mM DTT, 5% Trehalose and Proclin300.
-
复溶方法
Reconstitute in ddH2O to a concentration of 0.1-0.5 mg/mL. Do not vortex.
- 个性化定制
-
稳定性测试
The thermal stability is described by the loss rate. The loss rate was determined by accelerated thermal degradation test, that is, incubate the protein at 37℃ for 48h, and no obvious degradation and precipitation were observed. The loss rate isless than 8% within the expiration date under appropriate storage condition.
-
保存条件 & 期限
Samples are stable for up to twelve months from date of receipt at -20℃ to -80℃. Store it under sterile conditions at -20℃ to -80℃. It is recommended that the protein be aliquoted for optimal storage. Avoid repeated freeze-thaw cycles.
-
运输条件
In general, recombinant proteins are supplied as lyophilized powder and shipped at ambient temperature. For bulk packages, the proteins are provided as frozen liquid and shipped with blue ice, unless otherwise requested by the customer.
Quality inspection process
Related Products
Protein Description
DLST, or Dihydrolipoamide S-acetyltransferase, is an essential enzyme in the cellular metabolism of the 2-oxoglutarate and branched-chain alpha-ketoacid dehydrogenase complexes, playing a critical role in the mitochondrial energy production pathway. Research into DLST recombinant proteins has garnered attention due to their potential implications in understanding metabolic disorders and mitochondrial dysfunctions, which are linked to various diseases, including diabetes, neurodegenerative conditions, and cancer. By producing DLST in a recombinant form, researchers aim to elucidate its structural and functional characteristics, paving the way for insights into enzyme regulation and its interactions within multienzyme complexes. This work is crucial for elucidating the biochemical pathways in which DLST participates and may lead to the development of therapeutic strategies targeting metabolic diseases. Furthermore, recombinant DLST can be used as a tool to identify inhibitors or activators that could modulate its activity, providing avenues for drug development and precision medicine. Given the increasing prevalence of metabolic-related diseases globally, DLST research is positioned at the forefront of scientific inquiry that seeks to unravel complex metabolic networks and improve human health outcomes.
